2 replies to this topic

[Trey]

There is some encouraging news about a potential new drug that may help CML patients with T315i mutation and other types of TKI resistance.  Clinical trials (Phase II) are available:

 

https://ash.confex.c...Paper92676.html

 

http://bit.ly/2fbybkZ

https://clinicaltria...1&Search=Search

(Corrected link -- thanks Elvis)

Edited by Trey, 16 November 2016 - 09:03 PM.

[elvis]

Looks like the phase II is limited to AML.

[Trey]

Elvis,

 

I had previously posted the wrong link, so thanks.  I corrected the link above.